GB Sciences, Inc

GB Sciences, Inc. (OTCQB:GBLX) is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform plant-inspired drug development targeting novel treatments for multi-billion dollar biopharma markets. GB Sciences proprietary Generative-AI Powered Drug Discovery Platform (PhAROSTM) predicts novel, simple, plant-based mixtures to address multi-billion-dollar markets. PhAROSTM leverages demonstrated healing from within 12 global Traditional Medical Systems (TMS); pre-validates novel, simple, plant-based mixtures to address multi-billion-dollar markets; and goes beyond looking at what has worked within plant-based medicines in the past to predicting the efficacies of entirely new formulations that have not existed anywhere. GbS new proprietary mixtures often include components from different plants growing on different continents in different TMS that may never have been used together before. GB Sciences novel AI-powered dr...